Contraceptive injections by community health workers in Uganda: a nonrandomized community trial
John Stanback, Anthony K Mbonye, Martha Bekiita
Volume 85, Number 10, October 2007, 768-773
Table 2. Continuation and client reports of care received
| CRHW % (n = 449)a | Clinic % (n = 328)a | P-valueb | |
|---|---|---|---|
| Client received 2nd injection |
88 |
85 |
0.38 |
| Satisfied or highly satisfied with: |
|||
| provider care |
95 |
93 |
0.27 |
| DMPA as contraceptive method |
93 |
90 |
0.15 |
| Standard quality indicators: |
|||
| provider discussed side-effects |
85 |
86 |
0.49 |
| client received written appointment slip |
87 |
91 |
0.10 |
| provider discussed STI/HIV/AIDS |
69 |
71 |
0.58 |
| provider offered condoms |
36 |
34 |
0.64 |
| provider explained that DMPA does not protect against HIV |
80 |
81 |
0.75 |
| Spontaneous recall of other methods mentioned by family planning provider: |
|||
| pills |
86 |
89 |
0.21 |
| Norplant |
47 |
65 |
< 0.01 |
| IUD |
13 |
17 |
0.06 |
| female sterilization |
20 |
32 |
< 0.01 |
| condoms |
66 |
59 |
0.04 |
| Spontaneous recall of common side-effects: |
|||
| irregular bleeding |
55 |
54 |
0.74 |
| heavy bleeding |
49 |
49 |
0.97 |
| spotting |
25 |
33 |
0.03 |
| amenorrhoea |
15 |
20 |
0.08 |
| headache |
40 |
32 |
0.02 |
| weight gain |
26 |
32 |
0.04 |
| Injection-related problems reported:c |
|||
| infections/abscesses |
0.0 |
0.0 |
– |
| very painful injection |
0.7 |
0.0 |
0.27 |
| temporary numbness | 0.7 | 0.3 | 0.64 |
CRHW, community-based reproductive health workers; IUV, intrauterine device.a Maximum n for followed CRHW and clinic clients; some cells have non-response missing values.b P-values based on Mantel-Haenszel chi-square test, unless otherwise noted.c P-values based on Fisher’s exact test.